A comparative review of the safety and efficacy of bariatric surgery versus glucagon-like peptide-1 analogue
The values presented referred to the change of VAS scores from baseline
GLP-1 Receptor Agonist Market Key Takeaways Eli Lilly and Company, Sanofi, Novo-Nordisk A/S, AstraZeneca, Pfizer, Inc., Amgen, Inc., Innovent Biologics, Inc., PegBio Co., Ltd., Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH Increasing prevalence of chronic diseases such as diabetes and obesity Increasing R&D activities for developing novel therapeutics Formulation advancements of oral GLP-1 receptor agonists Adverse effects associated with few GLP-1 agonist drugs Product recalls by market players With the increasing prevalence of diabetes and obesity, GLP-1 receptor agonists have become popular due to their effectiveness in glycemic control and weight reduction, offering a dual benefit in managing type 2 diabetes mellitus (T2DM)
Trulicity images Your doctor will recommend the dosage of Trulicity thats right for you
Food Res (1947) 12:1228
Most long-acting GLP-1 receptor agonists (including semaglutide, liraglutide, and dulaglutide) also carry this warning, though not every short-acting agent does
